ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Researchers have found a way to take a pediatric patient's skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary ...

The findings come on the heels of the US Food and Drug Administration approving the Harmony system (Medtronic) in March as the first nonsurgical heart valve to treat pulmonary valve regurgitation in ...

Because they carry a higher reintervention rate, percutaneous pulmonary valves cost approximately $20,000 more than surgical valve replacement over 5-year follow-up. Even so, a shortened hospital stay ...

Abstract: - Global Transcatheter Pulmonary Valves Market to Reach $58.6 Million by 2027 - Amid the COVID-19 crisis, the global market for Transcatheter Pulmonary Valves estimated at US$39.8 Million in ...

Medtronic's Harmony valve, designed for congenital heart disease (CHD) patients with right ventricular outflow tract (RVOT) abnormalities, was shown to work in people without surgical right ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At 10 years, transcatheter pulmonary valve replacement ...

The FDA gave the greenlight to transcatheter pulmonic valve replacement with the Sapien 3 system plus an adaptive pre-stent landing zone, dubbed Alterra, for patients with congenital heart disease.

Isolated pulmonary-valve endocarditis is quite rare, but it shares demographic, clinical, and microbiologic features with the more-common tricuspid endocarditis. 1 We describe a 35-year-old ...

Researchers have found a way to take a pediatric patient’s skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary ...